Epigenetics in cancer genesis
Epigenetics in cancer genesis
Roundtable discussion on CLL: Expert insights from the iwCLL congress
First ‘targeted’ treatment for small cell lung cancer shows promise
Examining NSCLC responses to durvalumab monotherapy
PD-L2 expression and its relevance to anti-PD-1 therapy in cancer
NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs
RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours
Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL
Cytogenetic and proteomic prognostic markers of CLL
Predicting progression and survival in CLL
Expert panel discussion: The best of iwCLL 2015
Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells